Richard J. Jenny, PhD, President & Chief Executive Officer
Dr. Richard Jenny is an accomplished scientist and business entrepreneur with a unique balance of scientific, technical, business and people leadership skills with over 30 years of experience in the biotech industry.
Dr. Jenny received his B.S. degree in Chemistry/Mathematics from the University of Wisconsin – Eau Claire, and his Ph.D. Degree in Biochemistry from the University of Vermont. Upon completion of his Ph.D. degree, Dr. Jenny co-founded Haematologic Technologies, Inc., and has served as President, Chief Executive Officer and Chief Scientist for the past 29 years. Dr. Jenny has published 20 peer-reviewed academic papers, and has consulted for numerous diagnostic and biopharma companies.
Ryan Dorfman, PhD, Vice President, Operations
Dr. Dorfman has over 25 years of experience in the field of Protein Biochemistry with an expertise in Thrombosis and Hemostasis. He is an accomplished scientist, project leader, and manager in the biotech industry.
Dr. Dorfman received his B.S. degree in Biochemistry from the Marietta College, and his Ph.D. Degree in Biochemistry from Temple University. Since completion of his Ph.D. degree in 2000, Dr. Dorfman began working for Haematologic Technologies, Inc., and has served as Senior Scientist, Scientific Director, and Vice President of Operations. Currently, he provides scientific leadership and business acumen for both HTI and Haemtech Biopharma Services.
Robert Myers, MBA, Vice President, Business Development
Mr. Myers joined Haematologic Technologies in 1995, and has held both technical and business positions within the company. Currently, he provides strategic leadership for all marketing and business development activities for both HTI and Haemtech Biopharma Services, HTI’s QC testing division.
Mr. Myers holds a Bachelors degree in biology from the University of Vermont, and a MBA from the University of Vermont Grossman School of Business.
Vivian Bills, Finance Director/Chief Administration Officer
Ms. Bills joined Haematologic Technologies in 1995, and oversees the company’s functions of accounting, policies and procedures, financial analysis and reporting. She is responsible for all administrative services including office services, human resource and benefits management.
Ms. Bills received a Bachelor of Arts degree in English Literature from the University of Vermont.
John Maddalena, PhD, Vice President, Operations of Haemtech Biopharma Services
Dr. Maddalena joined Haematologic Technologies in 1992, and was responsible for the development and implementation of a Quality Management System (QMS), and subsequent ISO 9001 registration, to support HTI’s manufacturing activities. More recently, Dr. Maddalena assumed oversight responsibilities for Haemtech Biopharma Services, a division of HTI that focuses on providing analytical testing services to support the development and release of protein therapeutics. He specializes in the development and validation of analytical test methods.
Dr. Maddalena received his B.S. in Microbiology from the University of Notre Dame, and his Ph.D. in Cellular and Molecular Biology from the University of Vermont. Dr. Maddalena also holds a M.Ed. degree from the University of Massachusetts.